Sumitomo Chemical India Limited
NSE:SUMICHEM.NS
586.5 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28,439.47 | 35,109.68 | 30,403.19 | 26,277.08 | 23,975.24 | 21,829.06 | 18,908.99 | 7,961 | 7,642.79 |
| Cost of Revenue
| 20,692.81 | 22,706.29 | 19,167.06 | 16,616.92 | 16,138 | 14,653.7 | 12,445.14 | 5,315.26 | 5,138.85 |
| Gross Profit
| 7,746.66 | 12,403.39 | 11,236.13 | 9,660.16 | 7,837.24 | 7,175.36 | 6,463.85 | 2,645.74 | 2,503.94 |
| Gross Profit Ratio
| 0.272 | 0.353 | 0.37 | 0.368 | 0.327 | 0.329 | 0.342 | 0.332 | 0.328 |
| Reseach & Development Expenses
| 115.74 | 11.25 | 12.03 | 7.84 | 6.65 | 6.24 | 13.65 | 1.15 | 5.05 |
| General & Administrative Expenses
| 223.94 | 187.57 | 156.78 | 291.84 | 227.45 | 224.23 | 155.27 | 73.67 | 62.2 |
| Selling & Marketing Expenses
| 988.47 | 1,206 | 1,306.68 | 1,057 | 986.62 | 841.67 | 872.19 | 403.29 | 717.22 |
| SG&A
| 3,622.8 | 1,393.57 | 1,463.46 | 1,348.84 | 1,214.07 | 1,065.9 | 1,027.46 | 476.96 | 779.42 |
| Other Expenses
| 956.69 | 448.51 | 12.67 | 12.04 | 47.77 | 36.53 | 22.41 | 12.16 | 13.89 |
| Operating Expenses
| 3,622.8 | 6,256.2 | 5,651.95 | 5,005.77 | 4,836.65 | 4,537.24 | 4,183.75 | 1,592.32 | 1,435.57 |
| Operating Income
| 4,123.86 | 6,148.64 | 5,566.2 | 4,435.62 | 2,969 | 2,686.79 | 2,280.1 | 1,053.42 | 1,068.37 |
| Operating Income Ratio
| 0.145 | 0.175 | 0.183 | 0.169 | 0.124 | 0.123 | 0.121 | 0.132 | 0.14 |
| Total Other Income Expenses Net
| 905.62 | 393.12 | 191.11 | 97.37 | -303.79 | -88.36 | -70.44 | 10.17 | 2.14 |
| Income Before Tax
| 5,029.48 | 6,541.76 | 5,757.31 | 4,532.99 | 2,665.21 | 2,598.44 | 2,209.66 | 1,063.59 | 1,070.51 |
| Income Before Tax Ratio
| 0.177 | 0.186 | 0.189 | 0.173 | 0.111 | 0.119 | 0.117 | 0.134 | 0.14 |
| Income Tax Expense
| 1,332.04 | 1,519.67 | 1,521.86 | 1,078.93 | 618.26 | 940.47 | 758.48 | 426.21 | 424.24 |
| Net Income
| 3,695.41 | 5,022.09 | 4,235.58 | 3,453.05 | 2,046.95 | 1,657.97 | 1,451.18 | 637.38 | 646.25 |
| Net Income Ratio
| 0.13 | 0.143 | 0.139 | 0.131 | 0.085 | 0.076 | 0.077 | 0.08 | 0.085 |
| EPS
| 7.4 | 10.06 | 8.49 | 6.92 | 4.1 | 3.32 | 2.91 | 1.28 | 1.29 |
| EPS Diluted
| 7.4 | 10.06 | 8.49 | 6.92 | 4.1 | 3.32 | 2.91 | 1.28 | 1.29 |
| EBITDA
| 4,745.75 | 7,114.48 | 6,101.19 | 5,170.9 | 3,438.9 | 2,923.46 | 2,528.85 | 1,171.38 | 1,160.22 |
| EBITDA Ratio
| 0.167 | 0.203 | 0.201 | 0.197 | 0.143 | 0.134 | 0.134 | 0.147 | 0.152 |